-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-44 Prognostic Impact of Iron Overload and Iron Chelation in Myelodysplastic Syndromes

Program: Scientific Program
Session: Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism
Hematology Disease Topics & Pathways:
Anemias, Adult, Diseases, Non-Biological, Bone Marrow Failure, Therapies, chemical interactions, Elderly, MDS, Biological Processes, erythropoiesis, Study Population, Myeloid Malignancies, Clinically relevant, iron metabolism
Monday, December 7, 2020, 11:25 AM-11:30 AM

Norbert Gattermann, MD

Heinrich-Heine-Universitat, Dusseldorf, Germany

Disclosures: Gattermann: Novartis: Honoraria, Research Funding.

<< Previous Presentation | Next Presentation